Repligen financial statements

레플리젠NASDAQ:RGEN · Nasdaq · Healthcare · sector #13
$189.50+4.29%
2026-10-05 close

Repligen's published financial data is dated 2026-10-04. 2024 revenue was $634M. 2024 operating profit was −$35M.

Reported results

Repligen notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q